NHS National Generic Pharmaceuticals – Clozapine
Details
- Buyer
- NHS England
- Published
- 18 February 2025
- Submission
- 25 March 2025
- Source
- uk:atamis:dhsc
Tender description
NHS National Generic Pharmaceuticals – Clozapine Offer reference number: CM/PHG/22/5667 Period of framework agreement: 1st August 2025 to 31st July 2027, with an option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months.
Timeline
- Completed: Tender published18 February 2025Current notice
- Completed: Submission date25 March 2025
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
Related buyers
Buyers similar to NHS England.
- 514£249.6m
- 432£12.3bn
- 413£111.5m
- 391£652.7m
- 329£25.1bn
- 301£1.3bn
- 295£1.6bn
- 282£3.1bn
- 157£122.2m
- 148£1.0bn
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.